KolmarBNH
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
KolmarBNH develops and produces health supplements and cosmetics, everyday wellness products such as immune-support and digestive-health foods, as well as skincare, on an ODM/OEM basis, meaning it manufactures finished goods to other brands' specifications.
It supplies customers across South Korea and exports to more than two dozen countries, including China, the United States, and Japan. Listed on KOSDAQ, Korea's tech and small-cap board, the company earns the majority of its revenue from health supplements, with cosmetics making up most of the remainder.
Summary is AI-generated and may contain errors · figures from DART filings
A subsidiary, Geunoh Agriculture & Forestry Co., Ltd., grows and supplies raw botanical ingredients, including Korean medicinal herbs, directly to the group, giving it an in-house upstream materials capability.
KolmarBNH in five facts
What does KolmarBNH do?
KolmarBNH develops and produces health supplements and cosmetics, everyday wellness products such as immune-support and digestive-health foods, as well as skincare, on an ODM/OEM basis, meaning it manufactures finished goods to other brands' specifications.
Where is KolmarBNH listed and in which sector?
KolmarBNH (Korean name: 콜마비앤에이치) trades under KRX code 200130 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Pharmaceuticals.
How large is KolmarBNH?
Its market capitalisation was US$170.3M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were KolmarBNH's latest annual revenue and operating profit?
For fiscal year 2025, KolmarBNH reported revenue of US$433.9M, operating profit of US$20.1M and a net loss of US$17.1M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was down 6.6% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Report on large shareholdings (5% rule) (standard)Sep 30
- [Amended] Decision to acquire shares/equity in another company
KolmarBNH updated the disclosed terms of an acquisition, now worth US$14.7M.
M&A · Sep 2 · 2 versions - [Amended] Cash/in-kind dividend decision
KolmarBNH updated its declared cash dividend of US$0.04 per share, equal to about 0.7% of the recent share price.
Dividend · Aug 14 · 2 versions - Operating results (preliminary) (fair disclosure)
KolmarBNH filed provisional (unaudited) separate results for Q2 2026: revenue of US$88M (−2.9% year on year), operating profit of US$8.23M (+11.8% year on year) and net income of US$6.37M (+12.9% year on year).
Earnings · Jul 30 - Operating results (consolidated) (preliminary) (fair disclosure)
KolmarBNH filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$91.7M (+0.12% year on year), operating profit of US$6.92M (+188.55% year on year) and net income of US$15M (+1450.97% year on year).
Earnings · May 12 - [Amended] Business transfer (sale) decision (subsidiary)M&A · Apr 30 · 3 versions
- Decision to acquire shares/equity in another company
KolmarBNH disclosed an acquisition, worth US$18.9M.
M&A · Mar 6 - [Amended] Change of 30% or more in revenue or profit/loss structure (15% for large companies)
KolmarBNH updated its previously filed consolidated results for FY2025: revenue of US$389M (−6.6% year on year), operating profit of US$18M (+8.2% year on year) and a net loss of US$15.3M (from a profit a year earlier).
Earnings · Mar 6 · 2 versions